Methylthioninium injection (Methylthioninii injectio).
- Published in:
- WHO Drug Information, 2016, v. 30, n. 3, p. 468
- Publication type:
- Article
Works matching IS 10109609 AND DT 2016 AND VI 30 AND IP 3
Results: 59
1
2
Methylthioninium chloride (Methylthioninii chloridum).
- Published in:
- WHO Drug Information, 2016, v. 30, n. 3, p. 463
- Publication type:
- Article
3
Mebendazole chewable tablets (Mebendazoli compressi manducabili).
- Published in:
- WHO Drug Information, 2016, v. 30, n. 3, p. 459
- Publication type:
- Article
4
Mebendazole (Mebendazolum).
- Published in:
- WHO Drug Information, 2016, v. 30, n. 3, p. 455
- Publication type:
- Article
5
Ceftriaxone for injection (Ceftriaxoni ad injectionem).
- Published in:
- WHO Drug Information, 2016, v. 30, n. 3, p. 452
- Publication type:
- Article
6
Ceftriaxone sodium (Ceftriaxonum natricum).
- Published in:
- WHO Drug Information, 2016, v. 30, n. 3, p. 448
- Publication type:
- Article
7
Clindamycin phosphate injection (Clindamycini phosphatis injectio).
- Published in:
- WHO Drug Information, 2016, v. 30, n. 3, p. 445
- Publication type:
- Article
8
Clindamycin phosphate (Clindamycini phosphas).
- Published in:
- WHO Drug Information, 2016, v. 30, n. 3, p. 437
- Publication type:
- Article
9
Clindamycin palmitate hydrochloride (Clindamycini palmitas hydrochloridum).
- Published in:
- WHO Drug Information, 2016, v. 30, n. 3, p. 432
- Publication type:
- Article
10
Clindamycin palmitate for oral suspension (Clindamycini palmitas ad suspensionem peroralem).
- Published in:
- WHO Drug Information, 2016, v. 30, n. 3, p. 435
- Publication type:
- Article
11
Medroxyprogesterone injection (Medroxyprogesteroni injectio).
- Published in:
- WHO Drug Information, 2016, v. 30, n. 3, p. 429
- Publication type:
- Article
12
Chlorhexidine digluconate topical solution (Chlorhexidini digluconatis solutio topicalis).
- Published in:
- WHO Drug Information, 2016, v. 30, n. 3, p. 421
- Publication type:
- Article
13
Chlorhexidine digluconate solution (Chlorhexidini digluconatis solutio).
- Published in:
- WHO Drug Information, 2016, v. 30, n. 3, p. 414
- Publication type:
- Article
14
Publications and events.
- Published in:
- WHO Drug Information, 2016, v. 30, n. 3, p. 407
- Publication type:
- Article
15
Diagnostics.
- Published in:
- WHO Drug Information, 2016, v. 30, n. 3, p. 406
- Publication type:
- Article
16
Extensions of indications.
- Published in:
- WHO Drug Information, 2016, v. 30, n. 3, p. 406
- Publication type:
- Article
17
Biosimilar.
- Published in:
- WHO Drug Information, 2016, v. 30, n. 3, p. 405
- Publication type:
- Article
18
Approved.
- Published in:
- WHO Drug Information, 2016, v. 30, n. 3, p. 405
- Publication type:
- Article
19
Under discussion.
- Published in:
- WHO Drug Information, 2016, v. 30, n. 3, p. 404
- Publication type:
- Article
20
All U.S. blood donations to be screened for Zika virus.
- Published in:
- 2016
- Publication type:
- Excerpt
21
Shorter deferral period for MSM in Canada.
- Published in:
- 2016
- Publication type:
- Excerpt
22
Tighter control of W-18 in Canada.
- Published in:
- 2016
- Publication type:
- Excerpt
23
Tripartite meeting on evaluation of new antibacterial agents.
- Published in:
- 2016
- Publication type:
- Proceeding
24
Global implications of antibiotics control in India.
- Published in:
- WHO Drug Information, 2016, v. 30, n. 3, p. 402
- Publication type:
- Article
25
EMA recommends reducing veterinary use of colistin.
- Published in:
- WHO Drug Information, 2016, v. 30, n. 3, p. 401
- Publication type:
- Article
26
Improved product labels in Canada.
- Published in:
- WHO Drug Information, 2016, v. 30, n. 3, p. 401
- Publication type:
- Article
27
EMA adopts data integrity guidelines.
- Published in:
- WHO Drug Information, 2016, v. 30, n. 3, p. 401
- Publication type:
- Article
28
Report on pharmacovigilance activities in Europe.
- Published in:
- WHO Drug Information, 2016, v. 30, n. 3, p. 400
- Publication type:
- Article
29
New EMA guidance on monitoring of biological medicines.
- Published in:
- WHO Drug Information, 2016, v. 30, n. 3, p. 400
- Publication type:
- Article
30
EMA and FDA collaborate on patient engagement.
- Published in:
- WHO Drug Information, 2016, v. 30, n. 3, p. 399
- Publication type:
- Article
31
EMA report on adaptive pathways pilot.
- Published in:
- WHO Drug Information, 2016, v. 30, n. 3, p. 399
- Publication type:
- Article
32
Falsified quinine sulphate circulating in West and Central Africa.
- Published in:
- WHO Drug Information, 2016, v. 30, n. 3, p. 398
- Publication type:
- Article
33
Laxachem Organics Pvt Ltd, India: import ban for refusal of inspection.
- Published in:
- WHO Drug Information, 2016, v. 30, n. 3, p. 397
- Publication type:
- Article
34
Shanghai Desano Co Ltd, China: non-compliance with GMP.
- Published in:
- WHO Drug Information, 2016, v. 30, n. 3, p. 397
- Publication type:
- Article
35
Pharmaceutics International Inc., U.S.: non-compliance with GMP.
- Published in:
- WHO Drug Information, 2016, v. 30, n. 3, p. 397
- Publication type:
- Article
36
Zhejiang Medicine Co Ltd, China: unreported impurity testing results.
- Published in:
- WHO Drug Information, 2016, v. 30, n. 3, p. 396
- Publication type:
- Article
37
Semler Research Centre Pvt Ltd, India: EMA review concluded.
- Published in:
- WHO Drug Information, 2016, v. 30, n. 3, p. 396
- Publication type:
- Article
38
Quest Life Sciences Pvt Ltd, India: data integrity issues.
- Published in:
- WHO Drug Information, 2016, v. 30, n. 3, p. 395
- Publication type:
- Article
39
Alkem Laboratories Ltd, India: data integrity issues.
- Published in:
- WHO Drug Information, 2016, v. 30, n. 3, p. 395
- Publication type:
- Article
40
N-acetylcysteine and biochemistry assays.
- Published in:
- WHO Drug Information, 2016, v. 30, n. 3, p. 393
- Publication type:
- Article
41
Blood clotting time measuring devices: inaccurate readings.
- Published in:
- WHO Drug Information, 2016, v. 30, n. 3, p. 393
- Publication type:
- Article
42
Fingolimod: not proven in progressive multiple sclerosis.
- Published in:
- WHO Drug Information, 2016, v. 30, n. 3, p. 393
- Publication type:
- Article
43
Apixaban: Liver function disorder.
- Published in:
- WHO Drug Information, 2016, v. 30, n. 3, p. 393
- Publication type:
- Article
44
Canaglilozin, dapaglilozin: kidney injury.
- Published in:
- WHO Drug Information, 2016, v. 30, n. 3, p. 392
- Publication type:
- Article
45
Fluoroquinolones: use only in certain serious infections.
- Published in:
- WHO Drug Information, 2016, v. 30, n. 3, p. 392
- Publication type:
- Article
46
Riociguat: not for patients with pulmonary hypertension caused by idiopathic interstitial pneumonia.
- Published in:
- WHO Drug Information, 2016, v. 30, n. 3, p. 392
- Publication type:
- Article
47
Citalopram: suspected drug interaction with cocaine.
- Published in:
- WHO Drug Information, 2016, v. 30, n. 3, p. 391
- Publication type:
- Article
48
Levetiracetam: acute renal failure.
- Published in:
- WHO Drug Information, 2016, v. 30, n. 3, p. 391
- Publication type:
- Article
49
Opioids and benzodiazepines: potentially fatal side effects.
- Published in:
- WHO Drug Information, 2016, v. 30, n. 3, p. 391
- Publication type:
- Article
50
Idelalisib: updated measures to manage risk of infections.
- Published in:
- WHO Drug Information, 2016, v. 30, n. 3, p. 390
- Publication type:
- Article